Nagapetir represents a novel medical method targeting activated protein C, a crucial element in the clotting process. This agent functions as a specific protease inhibitor, demonstrating promise in lessening blood clot events. Preclinical investigations have shown favorable data, suggesting that Nagapetir may present a alternative possibility for t